Hypoglycemia

REDWOOD CITY, Calif. — September 9, 2026 Rezolute, Inc. provided an update on the U.S. Food and Drug Administration’s...

CAMBRIDGE, Mass., August 18, 2026 Amylyx Pharmaceuticals, Inc. announced positive topline results from the Phase 3 LUCIDITY clinical trial...